Growth Metrics

Pfizer (PFE) Short-term Investments (2016 - 2025)

Pfizer (PFE) has disclosed Short-term Investments for 17 consecutive years, with $12.5 billion as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 35.92% to $12.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.5 billion through Dec 2025, down 35.92% year-over-year, with the annual reading at $12.5 billion for FY2025, 35.92% down from the prior year.
  • Short-term Investments for Q4 2025 was $12.5 billion at Pfizer, down from $13.6 billion in the prior quarter.
  • The five-year high for Short-term Investments was $42.2 billion in Q3 2023, with the low at $6.0 billion in Q2 2024.
  • Average Short-term Investments over 5 years is $20.4 billion, with a median of $18.6 billion recorded in 2021.
  • The sharpest move saw Short-term Investments surged 211.15% in 2021, then tumbled 85.65% in 2024.
  • Over 5 years, Short-term Investments stood at $29.1 billion in 2021, then dropped by 23.38% to $22.3 billion in 2022, then plummeted by 55.92% to $9.8 billion in 2023, then soared by 97.56% to $19.4 billion in 2024, then plummeted by 35.92% to $12.5 billion in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $12.5 billion, $13.6 billion, and $11.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.